Ultrasound Ablation for PD: Benefit Limited by Adverse Effects – Medscape

Related Articles:

• Catheter ablation in children and patients with congenital heart disease: Review of 1021 procedures at a high-volume single center in Japan. August 16, 2019 Catheter ablation in children and patients with congenital heart disease: Review of 1021 procedures at a high-volume single center in Japan. Heart Rhythm. 2019 Aug 12;: Authors: Kato Y, Suzuki T, Yoshida Y, Ozaki N, Aoki H, Kishimoto S, Yoshida S, Watanabe S, Nakamura Y Abstract BACKGROUND: Although pediatric catheter ablation therapy has often been described, there are few reports…
• June 2, 2019 - Parkinson's Weekly Update June 1, 2019 Weekly Update - Highlights include: World Parkinson Congress 2019 heads to Kyoto, Japan for the epic battle of "Parkinson's Disease vs. Chopsticks - Will We Go Home Hungry?"; focused ultrasound and PD; NIH awards $3 million grant for 5-year PD exercise study; deteriorating financial skills, dementia and brain plaques; hockey pucks for Parkinson's; inspiring people with PD; how DBS changes…
• The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease. July 11, 2019 The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease. Mov Disord. 2019 Jul 10;: Authors: Moosa S, Martínez-Fernández R, Elias WJ, Del Alamo M, Eisenberg HM, Fishman PS Abstract MR-guided focused ultrasound is a novel, minimally invasive surgical procedure for symptomatic treatment of PD. With this technology, the ventral intermediate nucleus, STN, and internal globus pallidus…
• Ultrasound Approach Eases Dopaminergic Brain Damage in Mouse Model of Parkinson’s June 12, 2019 Using ultrasound coupled with the intravenous injection of microbubbles lessened brain damage in a mouse model of early Parkinson’s and may provide a noninvasive way to successfully deliver therapies into the brains of people with the disease, a study reports. A clinical trial with Alzheimer’s disease patients has been approved by the U.S. Food and Drug and Administration to test the safety…
• Phase 3 Study of Exablate Neuro Ultrasound System to Treat Parkinson’s Motor Symptoms Begins May 1, 2018 The first patient with advanced Parkinson’s has been treated in a pivotal Phase 3 trial using MRI-guided focused ultrasound to address major motor symptoms of the disease. The multisite, randomized, and double-blinded clinical trial (NCT03319485) is evaluating the safety and effectiveness of MRI-guided focused ultrasound delivered to affected brain areas using Insightec’s Exablate Neuro system. It plans to enroll more than 100 patients…
• Focused ultrasound thalamotomy location determines clinical benefits in patients with essential tremor. July 16, 2019 Related ArticlesFocused ultrasound thalamotomy location determines clinical benefits in patients with essential tremor. Brain. 2018 12 01;141(12):3405-3414 Authors: Boutet A, Ranjan M, Zhong J, Germann J, Xu D, Schwartz ML, Lipsman N, Hynynen K, Devenyi GA, Chakravarty M, Hlasny E, Llinas M, Lozano CS, Elias GJB, Chan J, Coblentz A, Fasano A, Kucharczyk W, Hodaie M, Lozano AM Abstract Magnetic…
• Ultrasound Can Reduce Tremors in Severe Cases of Parkinson’s, Study Suggests November 15, 2017 Ultrasound therapy can reduce the tremors of Parkinson’s patients who fail to respond to medication, a small clinical trial suggests. While the results were encouraging, larger studies are needed to confirm the technique’s effectiveness, researchers at the University of Virginia School of Medicine said. The study raises the possibility that severe tremors can be treated without brain surgery, since the ultrasound…
• MRI-Focused Ultrasound Undergoing Phase 3 Clinical Trial for Parkinson’s Treatment March 2, 2018 New technology that uses MRI-guided focused ultrasound to target areas of the brain affected by Parkinson’s disease and improve motor symptoms will be further tested in a pivotal Phase 3 clinical trial. Led by the University of Maryland Medical Center (UMMC) and the University of Maryland School of Medicine (UMSOM), the randomized trial will assess the safety and effectiveness of…
• Ultrasound-activated Neurons Used to Study Parkinson’s, Other Neurodegenerative Diseases March 18, 2020 Using an engineered sound-sensitive protein, researchers have developed neurons that can be activated by ultrasound. This could be useful in studying, and even developing therapies for, neurological diseases, including Parkinson’s. The study, “Sonogenetic Modulation of Cellular Activities Using an Engineered Auditory-Sensing Protein,” was published in Nano Letters. The ability to control neuronal activity in a non-invasive manner is useful for basic…
• Opening the Blood-Brain Barrier: New Treatment for Parkinson’s in Phase 1 Trial November 18, 2020 A new Phase 1 clinical trial has been in the news this month offering hope and enthusiasm in the field of Parkinson’s research. This project led by Canadian researchers at Toronto’s Sunnybrook Health Sciences Centre and University Health Network would be a first-of-its-kind therapy for Canadians living with Parkinson’s. Lorraine Kalia, one of the lead investigators and a member of…
• [EFFECT OF GENDER ON OUTCOME OF TREATMENT FOR TREMOR WITH MRI GUIDED FOCUSED ULTRASOUND]. June 20, 2019 Related Articles[EFFECT OF GENDER ON OUTCOME OF TREATMENT FOR TREMOR WITH MRI GUIDED FOCUSED ULTRASOUND]. Harefuah. 2019 Jun;158(6):343-346 Authors: Schlesinger I, Sinai A, Nassar M, Eran A, Zaaroor M Abstract INTRODUCTION: Thalamotomy is an effective treatment for medication-resistant tremor. MRI-guided focused ultrasound (MRgFUS) has been shown to be an effective and safe treatment for alleviating tremor. OBJECTIVES: We examined whether…
• Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease. May 29, 2019 Focused ultrasound opening of the blood-brain barrier for treatment of Parkinson's disease. Mov Disord. 2019 May 28;: Authors: LeWitt PA, Lipsman N, Kordower JH Abstract The expanding landscape of options for Parkinson's disease (PD) therapeutics calls for novel ways to improve delivery of treatments to counteract neurodegeneration or enhance symptomatic control. This unmet need is particularly relevant for opportunities in…
• First Parkinson’s Patient Treated with Insightec’s Incisionless Brain Therapy May 11, 2018 Insightec has treated the first patient in a pivotal study of its non-invasive ultrasound therapy, ExAblate Neuro, for patients with advanced Parkinson’s who have not responded to medication. The device uses focused ultrasound and magnetic resonance imaging (MRI) to destroy a target deep in the brain — the Vim nucleus of the thalamus — through an intact skull. This area has been…
• Focused-ultrasound Lesion Surgery Can Treat Tremors and Improve Life Quality, Study Says December 5, 2018 Treating tremor in Parkinson’s patients using non-invasive and focused-ultrasound lesion surgery is associated with better quality of life when compared to deep brain stimulation, although both approaches are equally effective in easing this disease symptom, a review study reports. The study, “Outcomes in Lesion Surgery versus Deep Brain Stimulation in Patients with Tremor: A Systematic Review and Meta-analysis,” was published in the journal World Neurosurgery.…
• Deep Brain Stimulation Technique Lessens Parkinson’s Dyskinesia, Study Finds January 22, 2019 Using a parameter called interleaving stimulation (ILS) in deep brain stimulation (DBS) eased dyskinesia — involuntary, jerky movements — in patients with Parkinson’s, according to a new study. In contrast, the benefits in people with tremor or dystonia — abnormal muscle tone — or in mitigating DBS-induced adverse side effects were not as evident. The study, “Interleaving Stimulation in Parkinson’s Disease, Tremor, and Dystonia,” was published…
• Ultrasound Ablation for PD: Benefit Limited by Adverse Effects December 24, 2020 Focused ultrasound subthalamotomy improved motor features in patients with Parkinson's disease, but was associated with a high rate of adverse events in a new sham-controlled trial. Medscape Medical News
• Focused ultrasound in Parkinson's disease: A twofold path toward disease modification. August 15, 2019 Focused ultrasound in Parkinson's disease: A twofold path toward disease modification. Mov Disord. 2019 Aug 14;: Authors: Foffani G, Trigo-Damas I, Pineda-Pardo JA, Blesa J, Rodríguez-Rojas R, Martínez-Fernández R, Obeso JA Abstract A major unmet need in Parkinson's disease (PD) is to slow the inexorable progression of neurodegeneration. Clinical trials that evaluated promising pharmacological strategies have repeatedly failed. Nonetheless, the…
• A “world-first” trial for Parkinson’s disease November 5, 2020 In a groundbreaking new clinical trial, scientists are using ultrasound technology to deliver therapy to specific brain regions affected by Parkinson’s disease Researchers in Canada are using focused ultrasound technology to deliver a Parkinson’s treatment directly to areas of the brain that are affected by the condition. With focused ultrasound, researchers can reach deep regions of the brain without cutting…
• Trend and risk factors of recurrence and complications after arrhythmias radiofrequency catheter ablation: a nation-wide observational study in Taiwan. June 4, 2019 Related ArticlesTrend and risk factors of recurrence and complications after arrhythmias radiofrequency catheter ablation: a nation-wide observational study in Taiwan. BMJ Open. 2019 May 30;9(5):e023487 Authors: Lin Y, Wu HK, Wang TH, Chen TH, Lin YS Abstract OBJECTIVES: This study determined the recurrence and complication rates after radiofrequency catheter ablation (RFCA) for those with paroxysmal supraventricular tachycardia (PSVT), Wolff-Parkinson-White syndrome…
• New Gene Therapy Technique Gets Past Blood-brain Barrier, Mouse Study Shows March 4, 2020 A new technique using tiny bubbles and ultrasound waves could ease the way for gene therapy to be delivered to the central nervous system, a mouse study suggests. The technique had a neuroprotective effect on mice, and those treated to model Parkinson’s showed improvements in measurements of motor function, the study found. The study, “Ultrasound-responsive neurotrophic factor-loaded microbubble-liposome complex: Preclinical…
• Parkinson's Disease News - Editor's Picks (Archive 2016.11) March 17, 2017 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed Neurons Paralyze Us During REM SleepIt will also be most useful in the study of Parkinson’s disease, since these pathologies are related. This work was published on December 12, 2016 on the website of the journal Brain.…
• Magnetic resonance-guided focused ultrasound for Parkinson's disease since ExAblate, 2016-2019: a systematic review. January 4, 2021 Related ArticlesMagnetic resonance-guided focused ultrasound for Parkinson's disease since ExAblate, 2016-2019: a systematic review. Neurol Sci. 2021 Jan 03;: Authors: Lennon JC, Hassan I Abstract INTRODUCTION: ExAblate received FDA approval for treatment of a range of movement disorders in 2016, including tremor-dominant Parkinson's disease (TDPD), dyskinetic PD, and essential tremor. This incisionless device allows for magnetic resonance-guided focused ultrasound (MRgFUS)…